KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $136,630 | -79.6% | 17,383 | -82.4% | 0.00% | -66.7% |
| Q4 2022 | $669,341 | -86.7% | 99,015 | -71.5% | 0.00% | -90.0% |
| Q3 2022 | $5,037,000 | +8.9% | 347,125 | -26.1% | 0.03% | -57.7% |
| Q2 2022 | $4,625,000 | -33.2% | 470,000 | 0.0% | 0.07% | -16.5% |
| Q1 2022 | $6,928,000 | +11.4% | 470,000 | 0.0% | 0.08% | +34.9% |
| Q4 2021 | $6,218,000 | +196.9% | 470,000 | +291.7% | 0.06% | +600.0% |
| Q3 2021 | $2,094,000 | -27.2% | 120,000 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $2,875,000 | -6.7% | 120,000 | 0.0% | 0.02% | -5.9% |
| Q1 2021 | $3,083,000 | +83.0% | 120,000 | +103.8% | 0.02% | -26.1% |
| Q1 2019 | $1,685,000 | +182.7% | 58,871 | +94.9% | 0.02% | +109.1% |
| Q4 2018 | $596,000 | – | 30,201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |